Cohort four can't start until AT LEAST eight weeks after patient 8. Only patient 7 has been dosed as of two days ago. No Q4 efficacy report is possible unless patient eight is done this week.
Allowing for the usual delays, for which P French has found someone else (FDA) to blame, we will not find patient nine until the end of January...... if we are lucky.
New interview, page-37
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)